4//SEC Filing
Hannah Brendan 4
Accession 0001415889-25-003613
CIK 0001662774other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:41 PM ET
Size
5.7 KB
Accession
0001415889-25-003613
Insider Transaction Report
Form 4
Hannah Brendan
CBO, COO and CCO
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-28+450,000→ 450,000 totalExercise: $1.60Exp: 2035-01-27→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2025, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001929422
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 5:41 PM ET
- Size
- 5.7 KB